Eli Lilly and Company
The Director, Analytical Development & Quality Control at Eli Lilly leads the development and validation of phase-appropriate analytical methods for radiopharmaceutical imaging agents across preclinical to commercial stages. The role ensures cGMP compliance and product integrity, provides oversight of external CMOs/CROs, and manages the AD/QC laboratory and team to support regulatory and development objectives.
Headquarters
Indianapolis, Indiana, United States
Company Size
10001+ employees
Founded
1876
Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eli Lilly and Company.
Li Auto OTA Upgrade And Charging Use Test Investor Patience
1 week ago
Senior Scientist, Analytical Development
Neurocrine Biosciences
Director, Analytical Development
Crinetics Pharmaceuticals
Scientific Director, Analytical Development
Neurocrine Biosciences
Analytical Project Senior Scientist
AstraZeneca
Senior Scientist, Analytical Development
PTC Therapeutics
Scientist II, Analytical Development
PepGen